Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment
Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …
Hepatocellular carcinoma: current management and perspectives for the future
NN Rahbari, A Mehrabi, NM Mollberg, SA Müller… - Annals of …, 2011 - journals.lww.com
Objective: To review the literature on current management of hepatocellular carcinoma
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
Impact of pretransplant bridging locoregional therapy for patients with hepatocellular carcinoma within Milan criteria undergoing liver transplantation: analysis of 3601 …
VG Agopian, MP Harlander-Locke, RM Ruiz… - Annals of …, 2017 - journals.lww.com
Objective: To evaluate the effect of pretransplant bridging locoregional therapy (LRT) on
hepatocellular carcinoma (HCC) recurrence and survival after liver transplantation (LT) in …
hepatocellular carcinoma (HCC) recurrence and survival after liver transplantation (LT) in …
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Treatment of hepatocellular carcinoma (HCC) is dependent on the stage of the disease.
Intermediate stage HCC encompasses the largest subgroup of patients with the disease …
Intermediate stage HCC encompasses the largest subgroup of patients with the disease …
Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome
Background and Aims Although terlipressin and albumin are effective at treating acute
kidney injury‐hepatorenal syndrome (AKI‐HRS), liver transplantation (LT) is the best …
kidney injury‐hepatorenal syndrome (AKI‐HRS), liver transplantation (LT) is the best …
[HTML][HTML] A multistep, consensus-based approach to organ allocation in liver transplantation: toward a “blended principle model”
U Cillo, P Burra, V Mazzaferro, L Belli, AD Pinna… - American Journal of …, 2015 - Elsevier
Since Italian liver allocation policy was last revised (in 2012), relevant critical issues and
conceptual advances have emerged, calling for significant improvements. We report the …
conceptual advances have emerged, calling for significant improvements. We report the …
[HTML][HTML] Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate
The practice of treating candidates for liver transplantation (LT) for hepatocellular carcinoma
(HCC), with locoregional therapies, is common in most transplant centers. However, for T1 …
(HCC), with locoregional therapies, is common in most transplant centers. However, for T1 …
[HTML][HTML] Prognostic factors for hepatocellular carcinoma recurrence
The recurrence of hepatocellular carcinoma, the sixth most common neoplasm and the third
leading cause of cancer-related mortality worldwide, represents an important clinical …
leading cause of cancer-related mortality worldwide, represents an important clinical …
[HTML][HTML] Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma
Patients with hepatocellular carcinoma should be managed with a multidisciplinary
approach framed in a network where all the diagnostic techniques and therapeutic …
approach framed in a network where all the diagnostic techniques and therapeutic …
Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 …
Objectives: To evaluate the rate, effect, and predictive factors of a complete pathologic
response (cPR) in patients with hepatocellular carcinoma (HCC) undergoing locoregional …
response (cPR) in patients with hepatocellular carcinoma (HCC) undergoing locoregional …